Development and preliminary validation of a pain measure specific to neuropathic pain
- 1 February 1997
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 48 (2), 332-338
- https://doi.org/10.1212/wnl.48.2.332
Abstract
Article abstract-Neuropathic pain syndromes are commonly seen in clinical practice and are frequently used as pain models in testing new therapies. However, no pain scale exists with the primary purpose to measure pain in neuropathic syndromes. This paper describes the development and preliminary validation of the Neuropathic Pain Scale (NPS), which is designed to assess distinct pain qualities associated with neuropathic pain. Results support the discriminant and predictive validity of the NPS items. Moreover, the NPS items appear to be sensitive to treatments known to impact neuropathic pain. These findings provide support for the further development of the NPS. NEUROLOGY 1997;48: 332-338Keywords
This publication has 6 references indexed in Scilit:
- Report from the International Association for the Study of Pain Task Force on cancer painJournal of Pain and Symptom Management, 1996
- Megadose corticosteroids in multiple sclerosisNeurology, 1994
- Halothane–Morphine Compared with High-Dose Sufentanil for Anesthesia and Postoperative Analgesia in Neonatal Cardiac SurgeryNew England Journal of Medicine, 1992
- On the production of neurologists in the United StatesNeurology, 1991
- EditorialPain, 1991
- Ratio scales of sensory and affective verbal pain descriptorsPain, 1978